BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23021046)

  • 21. [Immunohistochemistry contribution in melanocytic lesions analysis].
    Castillo C
    Ann Pathol; 2011 Nov; 31(5 Suppl):S113-4. PubMed ID: 22054445
    [No Abstract]   [Full Text] [Related]  

  • 22. Epithelial membrane antigen staining of melanocytic nevi.
    Cramer SF
    Hum Pathol; 1990 Jan; 21(1):121-2. PubMed ID: 2295503
    [No Abstract]   [Full Text] [Related]  

  • 23. Nodal melanocytic nevus with balloon-cell change (nodal balloon-cell nevus).
    Urso C
    J Cutan Pathol; 2008 Jul; 35(7):672-6. PubMed ID: 18312441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
    Takahashi H; Strutton GM; Parsons PG
    Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferative nodules with balloon-cell change in a large congenital melanocytic nevus.
    McGowan JW; Smith MK; Ryan M; Hood AF
    J Cutan Pathol; 2006 Mar; 33(3):253-5. PubMed ID: 16466515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
    Barnhill RL
    Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
    Speeckaert R; van Geel N; Vermaelen KV; Lambert J; Van Gele M; Speeckaert MM; Brochez L
    Pigment Cell Melanoma Res; 2011 Apr; 24(2):334-44. PubMed ID: 21029398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.
    Edelson RL; Hearing VJ; Dellon AL; Frank M; Edelson EK; Green I
    Clin Immunol Immunopathol; 1975 Nov; 4(4):557-68. PubMed ID: 1081937
    [No Abstract]   [Full Text] [Related]  

  • 31. Idiosyncrasies of scalp melanoma.
    Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
    Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologic diagnosis of pigmented lesions of the skin.
    González SB
    Pathol Res Pract; 1991 May; 187(4):387-431. PubMed ID: 1876524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reporting melanocytic lesions: the form, substance, and the void].
    Urso C
    Pathologica; 2001 Jun; 93(3):253-7. PubMed ID: 11433624
    [No Abstract]   [Full Text] [Related]  

  • 34. Rejection-mediated regression of melanocytic naevi in an immunosuppressed organ transplant recipient.
    Zonta E; Brumana MB; Montin A; Piaserico S; Belloni-Fortina A; Alaibac M
    Acta Derm Venereol; 2014 Nov; 94(6):733-4. PubMed ID: 24682255
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and Dermoscopic Evaluation of Melanocytic Lesions in Patients with Chronic Graft Versus Host Disease.
    Barreiro-Capurro A; Mascaró JM; Galindo BA; Giavedoni P; Carrera C; Alos L; Puig S; Malvehy J
    Acta Derm Venereol; 2019 Jul; 99(9):777-782. PubMed ID: 30938827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pigmented epithelioid melanocytoma.
    Ward JR; Brady SP; Tada H; Levin NA
    Int J Dermatol; 2006 Dec; 45(12):1403-5. PubMed ID: 17184238
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunohistochemical study of HLA antigens and lymphocyte infiltration in melanocytic tumors.
    Kageshita T; Nagano H; Johno M; Ono T; Arao T; Imai K
    J Dermatol; 1986 Jun; 13(3):179-84. PubMed ID: 3537044
    [No Abstract]   [Full Text] [Related]  

  • 38. Granulomatous inflammation in nevi undergoing regression (halo phenomenon): a report of 6 cases.
    Denianke KS; Gottlieb GJ
    Am J Dermatopathol; 2008 Jun; 30(3):233-5. PubMed ID: 18496423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monoclonal antibodies in pigmented lesions].
    Puig L; Moreno A; Moragas JM
    Med Cutan Ibero Lat Am; 1987; 15(6):481-8. PubMed ID: 3323707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic phenotype of pigment cell lesions: a study of melanoma, its precursor lesions and heterogeneity in metastatic melanoma.
    Ernstoff MS; Duray P; Stenn K; Kirkwood JM
    J Invest Dermatol; 1985 May; 84(5):430-2. PubMed ID: 3889169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.